Search Results - Po‐Jung Su
- Showing 1 - 4 results of 4
-
1
Activated but not resting regulatory T cells accumulated in tumor microenvironment and correlated with tumor progression in patients with colorectal cancer by Yung‐Chang Lin, Jayashri Mahalingam, Jy‐Ming Chiang, Po‐Jung Su, Yu‐Yi Chu, Hsin‐Yi Lai, Jian‐He Fang, Ching‐Tai Huang, Cheng‐Tang Chiu, Chun‐Yen Lin
Published 2012Artigo -
2
Patient-reported Outcomes from JAVELIN Bladder 100: Avelumab First-line Maintenance Plus Best Supportive Care Versus Best Supportive Care Alone for Advanced Urothelial Carcinoma by Petros Grivas, Evgeny Kopyltsov, Po‐Jung Su, Francis Parnis, Se Hoon Park, Yoshiaki Yamamoto, Peter C.C. Fong, Christophe Tournigand, Miguel Á. Climent Durán, Aristotelis Bamias, Claudia Caserta, Jane Chang, Paul Cislo, Alessandra di Pietro, Jing Wang, Thomas Powles
Published 2022Artigo -
3
Avelumab First-line Maintenance for Advanced Urothelial Carcinoma: Long-term Analyses of Patient-reported Outcomes and Quality-adjusted Time Without Symptoms or Toxicity from the J... by Petros Grivas, Jeanny B. Aragon‐Ching, Joaquim Bellmunt, Yohann Loriot, Miguel Á. Climent Durán, Srikala S. Sridhar, Po‐Jung Su, Se Hoon Park, Evgeny Kopyltsov, Yoshiaki Yamamoto, Natalia Jacob, Jason Hoffman, Karin Tyroller, Juliane Manitz, Mairead Kearney, Michael Schlichting, Thomas Powles
Published 2025Artigo -
4
Circulating Tumour Cells as an Independent Prognostic Factor in Patients with Advanced Oesophageal Squamous Cell Carcinoma Undergoing Chemoradiotherapy by Po‐Jung Su, Min‐Hsien Wu, Hung‐Ming Wang, Chia-Lin Lee, Wen‐Kuan Huang, Chiao‐En Wu, Hsien‐Kun Chang, Yin‐Kai Chao, Chen‐Kan Tseng, Tzu-Keng Chiu, Nina Ming-Jung Lin, Siou-Ru Ye, Jane Ying-Chieh Lee, Chia‐Hsun Hsieh
Published 2016Artigo
Search Tools:
Related Subjects
Internal medicine
Medicine
Cancer
Oncology
Avelumab
Bladder cancer
Cancer research
Immunotherapy
Metastatic Urothelial Carcinoma
Urothelial carcinoma
Basal cell
Biochemistry
Biology
Carcinoma
Chemoradiotherapy
Clinical endpoint
Colorectal cancer
Confidence interval
Cytokine
Cytotoxic T cell
Engineering
Esophageal squamous cell carcinoma
FOXP3
Gemcitabine
Hazard ratio
IL-2 receptor
Immune system
Immunology
In vitro
Javelin